Skip to main content

Profound Medical Corp.

For the period ended Jun 30, 2026. Filed Aug 6, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 6, 2026

PROF$7.68+4.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(USD in thousands, except per share data)

​​​​​​​​​
​ · ​ · Three Months Ended June 30, · ​ · Six Months Ended June 30,
​​ ​ ​2026​ ​ ​2025​ ​ ​2026​ ​ ​2025
​​$​$​$​$
Revenue (note 12)​​​​​​​​
Recurring - non-capital1,6121,561​4,0863,362
Capital equipment871650​3,7341,470
​2,4832,211​7,8204,832
Cost of sales536593​2,0411,361
Gross profit1,9471,618​5,7793,471
​​​​​​​​​
Operating expenses​​​​​
Research and development5,6546,098​10,91610,906
Selling, general and administrative7,3599,326​13,95017,537
Total operating expenses13,01315,424​24,86628,443
​​​​​​​​​
Operating loss11,06613,806​19,08724,972
​​​​​​​​​
Other (income) expenses​​​​​
Net finance income(336)(343)​(713)(788)
Net foreign exchange (gain) loss(1,245)2,168​(1,861)2,130
Total other (income) expenses(1,581)1,825​(2,574)1,342
​​​​​​​​​
Net loss before income taxes9,48515,631​16,51326,314
​​​​​​​​​
Income tax expense6878​95119
Deferred tax recovery(13)(14)​(15)(14)
Total income tax expense​55​64​80​105
​​​​​​​​​
Net loss attributed to shareholders for the period9,54015,695​16,59326,419
​​​​​​​​​
Other comprehensive (income) loss​​​​​
Item that may be reclassified to (income) loss​​​​​
Foreign currency translation adjustment950(2,713)​1,955(2,816)
​​​​​​​​​
Net loss and other comprehensive loss for the period10,49012,982​18,54823,603
​​​​​​​​​
Loss per share (note 13)​​​​​
Basic and diluted net loss per common share0.260.52​0.460.88
Basic and diluted weighted average common shares outstanding36,350,66530,053,142​36,324,39330,055,047
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.